Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/16/22 → 09/20/25 |
Funding
- Parexel International LLC: $119,964.40
UCB Biopharma: A Double Blind Placebo Controlled Randomized 18 Month Phase 2A Study to Evaluate Efficacy Safety Tolerability & Pharmocokinetics of Oral UCB0599 in Study Participants with Early Parkinsons Disease
- Maurer, Carine (PI)
- Schwartz, Guy (CoPI)
Project: Research